methantheline has been researched along with Trigeminal Neuralgia in 2 studies
Methantheline: A quaternary ammonium compound that acts as an antimuscarinic agent. It has been used in the treatment of PEPTIC ULCER, in gastrointestinal disorders associated with smooth muscle spasm, and in the management of urinary incontinence, and may also be used for the treatment of HYPERHIDROSIS.
Trigeminal Neuralgia: A syndrome characterized by recurrent episodes of excruciating pain lasting several seconds or longer in the sensory distribution of the TRIGEMINAL NERVE. Pain may be initiated by stimulation of trigger points on the face, lips, or gums or by movement of facial muscles or chewing. Associated conditions include MULTIPLE SCLEROSIS, vascular anomalies, ANEURYSMS, and neoplasms. (Adams et al., Principles of Neurology, 6th ed, p187)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| STICH, MH | 1 |
2 other studies available for methantheline and Trigeminal Neuralgia
| Article | Year |
|---|---|
Effect of parasympatholytic drugs in trigeminal neuralgia.
Topics: Humans; Methantheline; Parasympatholytics; Quaternary Ammonium Compounds; Trigeminal Neuralgia | 1960 |
Banthine therapy of trigeminal neuralgia.
Topics: Humans; Methantheline; Parasympatholytics; Quaternary Ammonium Compounds; Trigeminal Neuralgia | 1952 |